Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.

Eline L GiraudPepijn W A ThomasJette A van LintEugene P van PuijenbroekTessa E H RömkensRachel L WestMaurice G V M RusselJeroen M JansenNaomi T JessurunFrank Hoentjennull null

Published in: Drug safety (2021)

Based on real-world data, ADR reporting demonstrated new ADRs and higher incidences of ADRs to IBD therapies. This information will contribute to drug safety by updating the SmPCs, allowing better risk assessment and communication towards patients.

Keyphrases

adverse drug
end stage renal disease
risk assessment
ejection fraction
newly diagnosed
chronic kidney disease
electronic health record
peritoneal dialysis
prognostic factors
healthcare
big data
working memory
machine learning
deep learning